Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 1 X post from an account with 2,794 followers.

New Research: Immune checkpoint inhibitor therapy increases systemic SDF-1, cardiac DAMPs Fibronectin-EDA, S100/Calgranulin, galectine-3, and NLRP3-MyD88-chemokine pathways: Background Immune checkpoint inhibitors (ICIs) have… https://t.co/URRebfWzku #car

11 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.